Milk thistle (Silybum marianum) is one of the most studied herbal compounds in hepatology — the science of liver function. It's also one of the most commercially oversimplified. Here's a clear look at what silymarin actually does, and why it earns its place in the Reeva formula.
What Silymarin Is
Silymarin is the collective name for a group of flavonolignans extracted from the seeds of the milk thistle plant. The primary active component is silybin (also called silibinin), which accounts for approximately 50–70% of silymarin extract and is responsible for most of its documented biological activity.
The Hepatoprotective Mechanisms
Silymarin works through several complementary pathways:
Membrane stabilisation. Silybin binds to receptors on liver cell (hepatocyte) membranes, altering their permeability and reducing the uptake of toxins — including alcohol metabolites — into the cell. This essentially creates a partial barrier against compounds that would otherwise damage liver cells.
Glutathione upregulation. Several studies have demonstrated that silymarin increases hepatic glutathione content — your liver's primary endogenous antioxidant. Alcohol metabolism depletes glutathione, leaving liver cells more vulnerable to oxidative damage. Silymarin helps maintain the reserve.
Anti-inflammatory activity. Silymarin inhibits the synthesis of prostaglandins and leukotrienes, two families of inflammatory mediators. This contributes to its hepatoprotective effect by reducing the inflammatory response that accompanies alcohol metabolism.
Protein synthesis stimulation. Silymarin appears to stimulate the activity of RNA polymerase I in hepatocytes, accelerating the synthesis of ribosomal proteins and supporting liver cell regeneration.
The Evidence Base
Milk thistle has an unusually extensive clinical evidence base for a botanical compound. It has been studied in the context of alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), toxic hepatitis, and as a general hepatoprotective agent.
A 2005 Cochrane review analysed 13 randomised trials involving 915 patients with alcoholic or hepatitis B or C liver diseases, finding that milk thistle was associated with significant reductions in liver-related mortality in patients with alcoholic liver disease.
More recent work has focused on silymarin's antioxidant and anti-inflammatory properties in the context of acute alcohol exposure — which is the context most relevant to Reeva.
Why It Pairs With Hovenia Dulcis
Hovenia dulcis (via DHM) and milk thistle operate through complementary mechanisms. DHM primarily supports the enzymatic breakdown of acetaldehyde and modulates GABA receptors. Milk thistle primarily protects liver cell membranes and maintains glutathione reserves.
Together, they address the two main vectors of alcohol-related liver stress — toxic metabolite accumulation and oxidative cell damage — from different angles. That complementarity is why both are central to the Reeva formula.